Clinical Development Infectious Diseases 

Clinical Development Oncology

Gradient_edited.png

IL-7 has an excellent safety record demonstrated on more than 440 treated patients

IL-7 is a naturally occurring cytokine produced by lymphoid stromal cells
IL-7 receptor self regulates as T Cell becomes more activated, it deceases IL-7 receptor expression.
(Mazzucchelli and Durum – Nat. Review Immunol. 7:144 2007.)
The clinical tolerance is considered as good and easy to manage by our clinical investigators.
 
                               
Most common side effects:
Injection site reactions
Occasional reversible grade I/II rash,
Rare transient elevated liver functions tests.
 
                               
Active autoimmunity is a contraindication.

© 2020 RevImmune. All Rights Reserved. Contact Us.

United States and Europe.